Yi Cao specialized in pattern recognition and bioinformatics during her PhD studies, graduating in 2024. Her research background encompasses developing databases and conducting drug screening by analyzing brain activity maps in zebrafish models. Additionally, she utilizes artificial intelligence and deep learning methods to identify spatial histopathological organization features for disease subtyping and prognosis—specifically targeting pancreatic ductal adenocarcinoma (PDAC), breast cancer (BC), and ulcerative colitis (UC)—to advance precision diagnostics and therapeutic discovery.